Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thymus Neoplasms 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms, Unknown Primary 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Brain Neoplasms 1 Adrenal Gland Neoplasms 1

Interventions

enzalutamide 33 Abiraterone Acetate 29 apalutamide 26 Prednisone 26 Radiotherapy 25 Magnetic Resonance Spectroscopy 25 Androgen Antagonists 24 Leuprolide 22 Radiosurgery 19 darolutamide 18 Docetaxel 17 Gonadotropin-Releasing Hormone 16 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15 Goserelin 13 gallium 68 PSMA-11 12 bicalutamide 12 Specimen Handling 12 Radiotherapy, Intensity-Modulated 12 abiraterone 11 Radiation 11 pembrolizumab 10 Pluvicto 10 Carboplatin 9 Brachytherapy 9 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 9 relugolix 8 luprolide acetate gel depot 8 Triptorelin Pamoate 8 Standard of Care 8 Nivolumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Prostatic Neoplasms × FAPI-46 × Clear all

NCT04457232 2025-07-15

FAPI PET Prost

Jonsson Comprehensive Cancer Center

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡